As per the perspectives of Payers, Patients, and Community with the Hepatitis B infection that can be considered as one of the diseases which is caused a substantial economic burden. Hepatitis Diseases, specifically in extreme cases, can be too expensive and costly for patients.
In a recent report from Iran government, Hepatitis B infection is still the main cause of chronic liver disease in Iran, which is associated with significant economic as well as social costs. Therefore, patients should be protected against more severe stages of the disease through proper treatment and early diagnosis. In recent within 10 years, health expenditure has increased considerably worldwide towards the treatment, vaccination of hepatitis B and C.
In addition to, because of the skyrocketing costs of health-related services, the health system of Iran has faced significant challenges. These costs may be generated directly by medical diagnostic services or indirectly by the loss of productivity and quality of life, as per the department of health, Iran.
Hepatitis B virus is now considered a serious health problem in the world so that it is the most common and most important type of viral hepatitis and liver disease taken into the account seriously by worldwide.
